-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2024.
- Reviva Pharmaceuticals Holdings, Inc. Depreciation for the quarter ending March 31, 2024 was $0.000.
- Reviva Pharmaceuticals Holdings, Inc. annual Depreciation for 2021 was $0.000, a 100% decline from 2020.
- Reviva Pharmaceuticals Holdings, Inc. annual Depreciation for 2020 was $591.000, a 8.37% decline from 2019.